Analyzing the Spatial Distribution of Immune Cells in Lung Adenocarcinoma

Author:

Almarii Florina12ORCID,Sajin Maria23,Simion George3,Dima Simona O.245,Herlea Vlad125

Affiliation:

1. Department of Pathology, Fundeni Clinical Institute, 022328 Bucharest, Romania

2. Department of Pathology, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania

3. Department of Pathology, Emergency University Hospital, 050098 Bucharest, Romania

4. Department of Surgery, Fundeni Clinical Institute, 022328 Bucharest, Romania

5. Department of Histopathology, The Center for Excellence in Translational Medicine, 022328 Bucharest, Romania

Abstract

(1) Background: This study investigates the tumor immune microenvironment, focusing on immune cell distribution in lung adenocarcinoma. (2) Methods: We evaluated fifty cases of lung adenocarcinoma, and suitable areas for further studies were annotated on the histological slides. Two tumor cores per case were obtained, one from the tumor’s center and another from its periphery, and introduced into three paraffin receptor blocks for optimized processing efficiency. The 4-micrometer-thick tissue microarray sections were stained for H&E and for CD68, CD163, CD8, CD4, and PD-L1; (3) Results: Our investigation revealed significant correlations between PD-L1 expression in tumor cells and the presence of CD163+ macrophages, between CD4+ cells and CD8+, CD68+, and CD163+ cells, and also between CD8+ T cells and CD163+ cells. Additionally, while we observed some differences in cellular components and densities between the tumor center and periphery, these differences were not statistically significant. However, distinct correlations between PD-L1 and immune cells in these regions were identified, suggesting spatial heterogeneity in the immune landscape. (4) Conclusions: These results emphasize the intricate interactions between immune cells and tumor cells in lung adenocarcinoma. Understanding patient spatial immune profile could improve patient selection for immunotherapy, ensuring that those most likely to benefit are identified.

Publisher

MDPI AG

Reference53 articles.

1. National Cancer Institute (2024, July 15). SEER Cancer Stat Facts: Lung and Bronchus Cancer, Available online: https://seer.cancer.gov/statfacts/html/lungb.html.

2. World Health Organization (2021). Thoracic tumours. WHO Classification of Tumours Editorial Board, International Agency for Research on Cancer. [5th ed.]. Available online: https://publications.iarc.fr/595.

3. Causes and Consequences of Lung Cancer Heterogeneity;Padhye;Am. J. Biomed. Sci. Res.,2022

4. An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure;Liu;Cell Rep. Med.,2024

5. Clonal neoantigens elicit T cell immunore-activity and sensitivity to immune checkpoint blockade;McGranahan;Science,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3